Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (251-260 of 365) with videos related to

Pageof 37
Sort By:
Clinical and Vaccine Immunology : CVI|January 17, 2014
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatriciansBenson Ogunjimi, Evelien Smits, Steven Heynderickx, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune ResponsesMarjolein R P Orije, Irene García-Fogeda, Wouter Van Dyck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical TrialPierre Van Damme, Myriam Bouillette-Marussig, Annick Hens, et al.
Plos One|November 5, 2016
Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly AdultsRajeka Lazarus, Sarah Kelly, Matthew D Snape, et al.
Human Vaccines & Immunotherapeutics|January 18, 2025
Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meetingSara Boccalini, Angela Bechini, Marco Del Riccio, et al.
Clinical and Experimental Hepatology|June 1, 2026
Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB)Robert Flisiak, Sona Frankova, Sakshi Jindal, et al.
Journal of the Pediatric Infectious Diseases Society|November 15, 2022
Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCVEsra Ekinci, Liesbet Van Heirstraeten, Laura Willen, et al.
Human Vaccines & Immunotherapeutics|April 1, 2025
Back to the future? Drastic drop in serotype 19A carriage in daycare centers within two years after a second switch to PCV13 in BelgiumEsra Ekinci, Eline Van den Bosch, Liesbet Van Heirstraeten, et al.
Plos One|June 24, 2025
"We have to amplify what we saw at EBOVAC" - Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods studyGwen Lemey, Ynke Larivière, Solange Milolo, et al.
Human Vaccines & Immunotherapeutics|March 20, 2018
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccineKarl-Ulrich Petry, Kaatje Bollaerts, Paolo Bonanni, et al.
Pageof 37

Showing results (251-260 of 365) with videos related to

Sort By:
Pageof 37
Clinical and Vaccine Immunology : CVI|January 17, 2014
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatriciansBenson Ogunjimi, Evelien Smits, Steven Heynderickx, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune ResponsesMarjolein R P Orije, Irene García-Fogeda, Wouter Van Dyck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical TrialPierre Van Damme, Myriam Bouillette-Marussig, Annick Hens, et al.
Plos One|November 5, 2016
Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly AdultsRajeka Lazarus, Sarah Kelly, Matthew D Snape, et al.
Human Vaccines & Immunotherapeutics|January 18, 2025
Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meetingSara Boccalini, Angela Bechini, Marco Del Riccio, et al.
Clinical and Experimental Hepatology|June 1, 2026
Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB)Robert Flisiak, Sona Frankova, Sakshi Jindal, et al.
Journal of the Pediatric Infectious Diseases Society|November 15, 2022
Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCVEsra Ekinci, Liesbet Van Heirstraeten, Laura Willen, et al.
Human Vaccines & Immunotherapeutics|April 1, 2025
Back to the future? Drastic drop in serotype 19A carriage in daycare centers within two years after a second switch to PCV13 in BelgiumEsra Ekinci, Eline Van den Bosch, Liesbet Van Heirstraeten, et al.
Plos One|June 24, 2025
"We have to amplify what we saw at EBOVAC" - Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods studyGwen Lemey, Ynke Larivière, Solange Milolo, et al.
Human Vaccines & Immunotherapeutics|March 20, 2018
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccineKarl-Ulrich Petry, Kaatje Bollaerts, Paolo Bonanni, et al.
Pageof 37